Allopurinol in Acute Gout

This study has been withdrawn prior to enrollment.
(because of a lack of funding)
Information provided by (Responsible Party):
Artur de Brum-Fernandes, Université de Sherbrooke Identifier:
First received: January 21, 2013
Last updated: December 10, 2013
Last verified: December 2013
The objectives of the present study are to determine if starting treatement of hyperuricemia with allopurinol during an acute gout crises has an impact on the duration or the severity of the crises

Condition Intervention
Drug: allopurinol

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator)
Primary Purpose: Treatment
Official Title: Allopurinol in Acute Gout

Resource links provided by NLM:

Further study details as provided by Université de Sherbrooke:

Primary Outcome Measures:
  • Duration of the gout crises [ Time Frame: First 7 days after visit ] [ Designated as safety issue: No ]
    Presence of inflammatory signs

Enrollment: 0
Study Completion Date: February 2013
Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Allopurinol
treatment with allopurinol
Drug: allopurinol
Placebo Comparator: placebo
placebo comparator


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

More than 18 years old Able to sign informed consent Indication of long-term treatment with allopurinol Acute gout crisis

Exclusion Criteria:

Les than 18 years-old Unable to consent Contra-indication to allopurinol

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

Responsible Party: Artur de Brum-Fernandes, Doctor, Université de Sherbrooke Identifier: NCT01775098     History of Changes
Other Study ID Numbers: Allopurinol in acute gout 
Study First Received: January 21, 2013
Last Updated: December 10, 2013
Health Authority: Canada: Health Canada

Keywords provided by Université de Sherbrooke:
uric acid

Additional relevant MeSH terms:
Genetic Diseases, Inborn
Joint Diseases
Metabolic Diseases
Metabolism, Inborn Errors
Musculoskeletal Diseases
Purine-Pyrimidine Metabolism, Inborn Errors
Rheumatic Diseases
Antirheumatic Agents
Enzyme Inhibitors
Free Radical Scavengers
Gout Suppressants
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs
Protective Agents processed this record on May 22, 2016